What's New

You may subscribe to this RSS feed.


New Board Positions Available

Applications are being accepted for a position on the ICCBBA Board of Directors. The Board is made up of experts in the fields of transfusion and transplantation from around the world. 

Board members may serve up to two consecutive three year terms. The initial term for these volunteer positions will begin in March 2020 and run through to 2023.

Applicants should send a cover letter explaining how their background and experience would be beneficial for the Board and a CV or resume to the ICCBBA Nominating Committee (boardnomination@iccbba.org). Questions about the positions or the organization may also be directed to boardnomination@iccbba.org.

https://www.iccbba.org/about-iccbba/board-of-directors4/new-board-positions-available

Closing date: 04 December 2020.


The Registered Facilities Database Has Been Updated

The Registered Facilities Database has been updated and is now available to licensed facilities. The database contains the names and locations of all ICCBBA-registered facilities worldwide and their assigned Facility Identification Numbers (FINs). It is available both as an Excel file (Registered Facilities.xlsx) and as a tab-delimited text file (Registered Facilities.txt).

Both files are available in the password-protected area of the website. Amendments to entries in these tables should be notified to the ICCBBA office.

For US facilities registered and/or licensed with the FDA, the name and location of your facility—as it appears in the Registered Facilities Database—should match what appears on your FDA registration and/or license.

[05 Sep 2020]


Version 7.42.0 of the ISBT 128 Product Description Code Database is Now Available and Includes New Codes for COVID-19 Convalescent Plasma

Version 7.42.0 of the ISBT 128 Product Description Code Database can be downloaded from the Product Description Code Database page.

In response to recent requests from blood transfusion services, ICCBBA has fast-tracked the release of new product description codes for COVID-19 Convalescent Plasma.

Please note that as of the release of version 7.0.0 of the database (Jan 06, 2017), various tables and fields that related to the old structure of the database were removed. For more information, see ST-010 ISBT 128 Standard Product Description Code Database.

[02 October 2020]


New Product Description Codes for High and Low Titer Covid-19 Convalescent Plasma will be Available by Early November

ICCBBA is responding to the FDA COVID-19 Convalescent Plasma EUA Decision Memorandum by introducing new product description codes to indicate high and low titer CCP. In order to implement the codes in an efficient manner, two new product description codes, one for high titer and one for low titer, will be created for all current U.S. requested CCP codes (92).  These codes will be available by the early November release of the PDC database.  Any additional codes needed can be requested via the normal code request process. The alternative practice of using special testing codes with current CCP product codes to designate the titer status of the product may continue to be utilized.

[30 September 2020]


Special Testing General Database v5.9.0

The Special Testing General Database v5.9.0 has been published.  In this version, the following N-codes for use in Data Structure 010 were added to indicate high and low titer antibodies to SARS-CoV-2.

  • N0137 = High titer for SARS-CoV-2 antibody
  • N0138 = Low titer for SARS-CoV-2 antibody

The updated database can be downloaded here.

[08 Sep 2020]


Document for Review - Labeling of Collection Products for Cellular Therapy Manufacturing

Labeling of Collection Products for Cellular Therapy Manufacturing - Draft

This draft Standard is being put out for public consultation and was developed by ICCBBA in collaboration with industry partners including: bluebird bio, Glaxo Smith Kline, Gilead Sciences, Johnson & Johnson, Juno Therapeutics, Kite Pharma, Legend Biotech, National Marrow Donor Program (NMDP/Be The Match, Deloitte, AABB, FACT, Standards Coordinating Body, Trakcel, Vineti, and subject matter experts in apheresis nursing and quality assurance.

The draft Standard builds on the existing ISBT 128 standards for cellular therapy and uses compatible label dimensions. It retains the essential ISBT 128 traceability information while also accommodating sponsor/manufacturer information in a standardized manner. It is a supplement to the ISBT 128 Standard Technical Specification (ST-001). It defines the labeling requirements for cellular therapy apheresis collection products for further processing by a clinical trials sponsor or a manufacturer. It is for use only in situations where the sponsor/manufacturer has adopted this standard and has provided the necessary information to populate the sponsor/manufacturer section of the label. While designed for apheresis collection products, the use of the label on collection products for further processing from other sources is not prohibited. Future versions of this standard may be extended to cover other sources of collection products.

We encourage you to review the draft Standard and provide any input you may have. Please submit your comments by October 18, 2020.


Version 3.23 of the GRID Issuing Organization Number Database is Now Available

The data files associated with the GRID Issuing Organization Number (ION) Database can be found here:

The specifications for the structure of the Global Registration Identifier for Donors (GRID) Issuing Organization Number (ION) and information on how to obtain and update an ION can now be found in the GRID Issuing Organization Number Database standards document (ST-015).

[05 Aug 2020]


OPERATIONS CONTINUE: CONTINGENCY PLANS IN PLACE

Dear customers, due to COVID-19 we are working under difficult circumstances. ICCBBA has plans in place and we will be making every effort to ensure that we continue to operate effectively. We ask that you please be patient during this time if things take longer than expected. Please feel free to continue to contact us with any questions or concerns.

[23 March 2020]


ICCBBA ONE WORLD AWARD RECIPIENT - 2019

Redlands, CA, July 22, 2019 – ICCBBA is proud to announce Ms. Suzanne H. Butch and Dr. Jørgen Georgsen as our two recipients of the 2019 One World Award. The ICCBBA One World Award was established in 2008 as a way of recognizing professionals who have made important and significant contributions to the understanding and application of international information standards in transfusion and transplantation medicine through original research, innovative technical development, and/or influence in the development of policy and regulation.

[22 July 2019]


ICCBBA Announces New Board Members

ICCBBA is proud to announce that three new members have been selected to serve on the organization’s Board of Directors: Dr. Zbigniew M. Szczepiorkowski, MD, PhD, FCAP, Dr. Kelly Tilleman, MD, PhD, and Professor Joy Mammen, MD.

[03 June 2019]


Version 1.2.0 of the Implementation Guide: Use of Flexible Date and Time [Data Structure 031] (IG-024) and version 1.3.0 of the Use of Dimensions [Data Structure 029] (IG-026) documents are now available

Version 1.2.0 of the Implementation Guide: Use of Flexible Date and Time [Data Structure 031] (IG-024) document is now available.

Version 1.3.0 of the Use of Dimensions [Data Structure 029] (IG-026) document is now available

[18 February 2019]


Version 1.0.0 of the ISBT 128 Standard Coding and Labeling of Medical Devices Containing MPHO (ST-017) is now available

Version 1.0.0 of the ISBT 128 Standard Coding and Labeling of Medical Devices Containing MPHO (ST-017) is now available. This document is intended to help facilities with labeling medical devices that contain Medical Products of Human Origin (MPHO) that are regulated as medical devices. It focuses on Unique Device Identification (UDI) labeling.

[22 February 2019]


ICCBBA Board Member Receives National Recognition for Work in the Field of Corneal Transplantation

ICCBBA would like to congratulate our current Board Member Professor John Armitage for being awarded the honor of Officer of the Most Excellent Order of the British Empire (OBE) in the United Kingdom’s 2019 New Year Honour List for his services to corneal transplantation.

The New Year Honours List recognizes the outstanding achievements of people across the United Kingdom and demonstrates the breadth of service given by people from all backgrounds. Of the 1,148 people who were named to this year’s list, only 238 individuals were selected at the OBE level. The list honors those who have overcome personal loss, helped rebuild communities, and whose expertise and dedication showcase the very best of the United Kingdom.

Professor Armitage has been an ICCBBA volunteer since 2010. In addition to his position on the Board of Directors, he also serves as the Chair of the international Eye Banking Technical Advisory Group and is a member of the Standards Committee.

Visit the link below to read more about Professor Armitage and this distinguishing achievement:

https://www.nhsbt.nhs.uk/media/professor-armitage-receives-obe/

 

 [17 January 2019]